Search Results 101-110 of 17021 for pharmacogenetics

  1. Pharmacogenomics (PGx) Results and Clinical Data of Established Patients with Liver Disease to Assess Current and Future Therapeutic Relevance of PGx Testing - Mayo Clinic

    About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing in established patients with ...

  2. Mayo Clinic Introduces Precision Medicine in Psychiatry

    ... pharmacogenetic guidelines for psychiatry. MEDIA CONTACT: Bob Nellis, Mayo Clinic Public Affairs, 507-284-5005, newsbureau@mayo.edu. These comments are ...

  3. Mayo Clinic Q and A: Genetic testing and antidepressants

    ANSWER: Genetic testing is available to help narrow down your antidepressant options, ideally reducing the need for a sometimes prolonged trial-and-error period ...

  4. Mayo Clinic Researchers Discover Genetic Markers for Alcoholism Recovery

    “This association finding is a first step towards development of a pharmacogenetic test allowing physicians to choose appropriate treatment for specific ...

  5. PGY-2 Pharmacy Residency in Clinical Pharmacogenomics at Mayo Clinic - Department and Faculty

    Learn about the department and faculty of the PGY-2 Clinical Pharmacogenomics Residency at Mayo Clinic in Rochester, Minnesota.

  6. Liewei Wang, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    D., is focused on pharmacogenomics, a critical component of individualized medicine that studies the role of inheritance in variation in drug response. Patients ...

  7. Janet E. Olson, Ph.D. - Mayo Clinic Faculty Profiles

    This study recently used pharmacogenetic (PGx) data on 11,000 subjects within the Mayo Clinic Biobank as part of the Right Drug, Right Dose, Right Time ...

  8. Pharmacogenomics and the Potential for Utilization of Testing Results for Patient Care in the Cardiac Surgical Intensive Care Unit - Mayo Clinic

    About this study. The overall goals of this pilot study are to: (1) describe pharmacogenomics (PGx) testing results and identify PGx variants that may ...

  9. Duan Liu, Ph.D. - Mayo Clinic Faculty Profiles

    EDUCATION. Postdoctoral Fellowship - Pharmacogenomics (Mentor: Richard Weinshilboum) Mayo Clinic; Ph.D. - Microbiology/Pharmacogenetics Northwest University; BS ...

  10. Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 - Mayo Clinic

    ... pharmacogenetics component of this study. Refusal to give consent for this component does not exclude a participant from participation in this clinical ...